Lv71
4040 积分 2021-01-03 加入
Low-Molecular-Weight Heparin Anti-Xa Guided Reversal of Apixaban With Prothrombin Complex Concentrate in a Patient on Hemodialysis
2个月前
已完结
Apixaban and rivaroxaban anti-Xa level utilization for guidance of administration of andexanet alfa: a case series
2个月前
已完结
Concentration Estimation of Apixaban and Rivaroxaban in Plasma From Patients Through Heparin‐Calibrated Anti‐Xa Assay Generated Different Results by Using 3 Reagent/Calibrators/Instrument Systems
2个月前
已完结
Comparison of Commercial Low Molecular Weight Heparin and Homemade Anti-Xa Calibrators to a Commercial Specific Anti-Xa Calibrator for Plasma Rivaroxaban Quantification by Anti-Xa Oral Anticoagulant Plasma Concentration Chromogenic Assay
2个月前
已完结
Apixaban and Rivaroxaban Anti-Xa Level Monitoring Versus Standard Monitoring in Hospitalized Patients With Acute Kidney Injury
2个月前
已完结
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
3个月前
已完结
Initiation and sequencing of guideline-directed medical therapy for heart failure across the ejection fraction spectrum
3个月前
已完结
Atrial fibrillation
3个月前
已完结
Atrial Fibrillation
3个月前
已完结
Atrial fibrillation: Epidemiology, pathophysiology, and clinical complications (literature review)
3个月前
已完结
皖公网安备34019202002308
